Literature DB >> 20020755

Molassamide, a depsipeptide serine protease inhibitor from the marine cyanobacterium Dichothrix utahensis.

Sarath P Gunasekera1, Margaret W Miller, Jason C Kwan, Hendrik Luesch, Valerie J Paul.   

Abstract

A new dolastatin 13 analogue, molassamide (1), was isolated from cyanobacterial assemblages of Dichothrix utahensis collected from the Molasses Reef, Key Largo, Florida, and from Brewer's Bay, St. Thomas, U.S. Virgin Islands. This is the first peptide reported from the cyanobacterial genus Dichothrix and the first natural product isolated from marine Dichothrix spp. Its planar structure was determined by NMR spectroscopic techniques, and the configurations of the asymmetric centers were assigned after chiral HPLC analysis of the hydrolysis products. The depsipeptide 1 exhibited protease-inhibitory activity, with IC(50) values of 0.032 and 0.234 muM against elastase and chymotrypsin, respectively. There was no apparent inhibition of trypsin at 10 microM, the highest concentration tested.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20020755     DOI: 10.1021/np900603f

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  20 in total

1.  Structural Diversity and Anticancer Activity of Marine-Derived Elastase Inhibitors: Key Features and Mechanisms Mediating the Antimetastatic Effects in Invasive Breast Cancer.

Authors:  Fatma H Al-Awadhi; Valerie J Paul; Hendrik Luesch
Journal:  Chembiochem       Date:  2018-03-23       Impact factor: 3.164

2.  Tutuilamides A-C: Vinyl-Chloride-Containing Cyclodepsipeptides from Marine Cyanobacteria with Potent Elastase Inhibitory Properties.

Authors:  Lena Keller; Kirley Marques Canuto; Chenxi Liu; Brian M Suzuki; Jehad Almaliti; Asfandyar Sikandar; C Benjamin Naman; Evgenia Glukhov; Danmeng Luo; Brendan M Duggan; Hendrik Luesch; Jesko Koehnke; Anthony J O'Donoghue; William H Gerwick
Journal:  ACS Chem Biol       Date:  2020-01-28       Impact factor: 5.100

3.  Antineoplastic agents. 590. X-ray crystal structure of dolastatin 16 and syntheses of the dolamethylleuine and dolaphenvaline units.

Authors:  George R Pettit; Thomas H Smith; Jun-Ping Xu; Delbert L Herald; Erik J Flahive; Collin R Anderson; Paul E Belcher; John C Knight
Journal:  J Nat Prod       Date:  2011-05-03       Impact factor: 4.050

4.  Depsipeptides from a Guamanian Marine Cyanobacterium, Lyngbya bouillonii, with Selective Inhibition of Serine Proteases.

Authors:  Brent K Rubio; Stephen M Parrish; Wesley Yoshida; Peter J Schupp; Tom Schils; Philip G Williams
Journal:  Tetrahedron Lett       Date:  2010-12-22       Impact factor: 2.415

5.  Stictamides A-C, MMP12 inhibitors containing 4-amino-3-hydroxy-5-phenylpentanoic acid subunits.

Authors:  Zhibin Liang; Analia Sorribas; Florian J Sulzmaier; Jorge I Jiménez; Xin Wang; Thomas Sauvage; Wesley Y Yoshida; Guangyi Wang; Joe W Ramos; Philip G Williams
Journal:  J Org Chem       Date:  2011-04-18       Impact factor: 4.354

6.  Stigonemapeptin, an Ahp-containing depsipeptide with elastase inhibitory activity from the bloom-forming freshwater cyanobacterium Stigonema sp.

Authors:  Hahk-Soo Kang; Aleksej Krunic; Jimmy Orjala
Journal:  J Nat Prod       Date:  2012-04-06       Impact factor: 4.050

7.  Sebestenoids A-D, BACE1 inhibitors from Cordia sebestena.

Authors:  Jingqiu Dai; Analia Sorribas; Wesley Y Yoshida; Philip G Williams
Journal:  Phytochemistry       Date:  2010-10-15       Impact factor: 4.072

Review 8.  Therapeutic potential of marine peptides in cervical and ovarian cancers.

Authors:  Salman Ahmed; Haroon Khan; Sajad Fakhri; Michael Aschner; Wai San Cheang
Journal:  Mol Cell Biochem       Date:  2021-12-02       Impact factor: 3.396

9.  Total synthesis and antimicrobial activity of a natural cycloheptapeptide of marine origin.

Authors:  Rajiv Dahiya; Hemendra Gautam
Journal:  Mar Drugs       Date:  2010-08-19       Impact factor: 5.118

10.  The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin L.

Authors:  Bailey Miller; Aaron J Friedman; Hyukjae Choi; James Hogan; J Andrew McCammon; Vivian Hook; William H Gerwick
Journal:  J Nat Prod       Date:  2013-12-23       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.